(Q68304118)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3354467%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

Propafenone for prevention of recurrent atrial fibrillation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3354467%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/0002-9149(88)90373-6

30 December 2022

author name string

C. R. Kerr

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3354467

30 December 2022

G. J. Klein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3354467

30 December 2022

J. E. Axelson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3354467

30 December 2022

J. C. Cooper

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3354467

30 December 2022

language of work or name

English

0 references

publication date

1 April 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3354467%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

15 April 1988

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=3354467

full work available at URL

30 December 2022

https://api.elsevier.com/content/article/PII:0002914988903736?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9149(88)90373-6

https://api.elsevier.com/content/article/PII:0002914988903736?httpAccept=text/plain

30 December 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9149(88)90373-6

American Journal of Cardiology

30 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3354467%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3354467%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3354467%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

914-916

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3354467%20AND%20SRC:MED&resulttype=core&format=json

Clinical pharmacology of propafenone

23 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9149(88)90373-6

Propafenone for the treatment of severe ventricular arrhythmias

30 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0002-9149(88)90373-6

Propafenone--a new antiarrhythmic drug

30 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0002-9149(88)90373-6

Electrophysiologic and hemodynamic effects of intravenous propafenone in patients with recurrent ventricular tachycardia

30 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-9149(88)90373-6

Electrophysiological effects of propafenone studied with programmed electrical stimulation of the heart in patients with recurrent paroxysmal supraventricular tachycardia

30 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-9149(88)90373-6

Indications and risks of anti-arrhythmia treatment with propafenone (author's transl)

30 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-9149(88)90373-6

Food increases the bioavailability of propafenone

30 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-9149(88)90373-6

Electrophysiological effects of propafenone in untreated and propafenone-pretreated guinea-pig atrial and ventricular muscle fibres

30 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-9149(88)90373-6

Inhibiton of $$\dot V_{\max } $$ of the action potential by propafenone and its voltage-, time- and pH-dependence in mammalian ventricular myocardium

30 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-9149(88)90373-6

Circus movement in rabbit atrial muscle as a mechanism of trachycardia

30 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-9149(88)90373-6

Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle

30 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-9149(88)90373-6

Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge

30 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-9149(88)90373-6

Correlation between serum concentration and pharmacological effect on atrioventricular conduction time of the antiarrhythmic drug propafenone

30 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0002-9149(88)90373-6

30 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3354467%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference